Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid (BRAVE-EPA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02719327
Recruitment Status : Recruiting
First Posted : March 25, 2016
Last Update Posted : April 17, 2019
Sponsor:
Collaborator:
University of Wisconsin, Madison
Information provided by (Responsible Party):
VA Office of Research and Development

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 30, 2021
Estimated Study Completion Date : November 30, 2021